| Bonnie Ramsey |
QAU145 ENAC Study Task Order #3 |
Novartis Pharmaceuticals Corporation |
$10,000 |
10/31/05 |
| David Suskind |
Maternal Microchimerism in Inflammatory Bowel Disease |
Broad (Eli and Edythe L.) Foundation |
$142,178 |
10/25/05 |
| Ghassan Wahbeh |
Multi-Center, Double-Blind Study of COLAZAL in the Treatment of 5- to 17-year Old Pediatric Subjects with Mild to Moderate Active Ulcerative Colitis |
Salix Pharmaceuticals, Inc. |
$133,100 |
10/21/05 |
| Bonnie Ramsey |
Consulting Services Agreement |
Berna Biotech |
$10,747 |
10/21/05 |
| Janet Englund |
Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically Significant Congenital Heart Disease |
PPD, Inc. |
$45,213 |
10/20/05 |
